3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: Chemical synthesis, evaluation in vitro and radiofluorination
摘要:
Aminocyclohexyl indoles bind with high affinity and specificity toward the serotonin transporter (SERT). Based on this structural lead, we designed fluoroalkoxydihydroisoquinoline-cyclohexyl indole carbonitriles for future application as F-18-labeled tracers for SERT imaging by PET. Six compounds, three pairs of cis- and trans-isomer derivatives, respectively, were synthesized and evaluated in vitro. The chemistry of the new compounds, their affinity and specificity data, the general route to the phenolic precursor for labeling, and the successful F-18-fluoroalkylation of one pair of compounds are described herein. (C) 2008 Elsevier Ltd. All Fights reserved.
3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: Chemical synthesis, evaluation in vitro and radiofluorination
摘要:
Aminocyclohexyl indoles bind with high affinity and specificity toward the serotonin transporter (SERT). Based on this structural lead, we designed fluoroalkoxydihydroisoquinoline-cyclohexyl indole carbonitriles for future application as F-18-labeled tracers for SERT imaging by PET. Six compounds, three pairs of cis- and trans-isomer derivatives, respectively, were synthesized and evaluated in vitro. The chemistry of the new compounds, their affinity and specificity data, the general route to the phenolic precursor for labeling, and the successful F-18-fluoroalkylation of one pair of compounds are described herein. (C) 2008 Elsevier Ltd. All Fights reserved.
[EN] TETRAHYDROISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF OBESITY AND DIABETES<br/>[FR] DÉRIVÉS DE TÉTRAHYDROISOQUINOLINE ET COMPOSITIONS PHARMACEUTIQUES UTILES POUR LE TRAITEMENT DE L'OBÉSITÉ ET DU DIABÈTE
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2016041845A1
公开(公告)日:2016-03-24
The invention relates to new pyrrolidine derivatives of the formula wherein R1 to R6, n and m are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof
申请人:Boehringer Ingelheim International GmbH
公开号:US20160075657A1
公开(公告)日:2016-03-17
The invention relates to new pyrrolidine derivatives of the formula
wherein R
1
to R
6
, n and m are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
TETRAHYDROISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF OBESITY AND DIABETES
申请人:Boehringer Ingelheim International GmbH
公开号:EP3194367B1
公开(公告)日:2021-08-18
US9340510B2
申请人:——
公开号:US9340510B2
公开(公告)日:2016-05-17
3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: Chemical synthesis, evaluation in vitro and radiofluorination
Aminocyclohexyl indoles bind with high affinity and specificity toward the serotonin transporter (SERT). Based on this structural lead, we designed fluoroalkoxydihydroisoquinoline-cyclohexyl indole carbonitriles for future application as F-18-labeled tracers for SERT imaging by PET. Six compounds, three pairs of cis- and trans-isomer derivatives, respectively, were synthesized and evaluated in vitro. The chemistry of the new compounds, their affinity and specificity data, the general route to the phenolic precursor for labeling, and the successful F-18-fluoroalkylation of one pair of compounds are described herein. (C) 2008 Elsevier Ltd. All Fights reserved.